Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) — The “De-identified Health Data Market Size, Share & Trends Analysis Report by Type Of Data (Clinical, Genomic), End-use (Pharmaceutical Companies, Biotechnology Firms), Application, Region, and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering.
The global de-identified health data market size is expected to reach USD 13.59 billion by 2030, registering a CAGR of 9% from 2024 to 2030.
The market’s growth is primarily driven by the rising demand for data analytics in healthcare, which supports population health studies and predictive modeling while ensuring patient privacy. Increasing regulatory pressure surrounding data protection, combined with AI and machine learning advancements, is creating a growing need for large-scale, de-identified datasets. In addition, the surge in data from wearables and electronic health records (EHRs) generates substantial volumes of information suitable for de-identification and secondary use, further boosting market demand.
De-identified data is utilized to derive insights into insurance status by analyzing patterns related to patient enrollment in pharmacy and medical insurance. This data enables organizations to identify primary and secondary payers, assess coverage trends, and understand patient demographics without compromising privacy. For instance, in June 2024, Komodo Health introduced the Komodo Patient Insurance (KPI). This novel data offering provides detailed insights into the insurance status of over 200 million de-identified U.S. patients. This resource accurately identifies patients’ pharmacy and medical insurance enrollment, detailing primary and secondary payer information across various channels, segments, and geographies. The KPI will assist Commercial, Market Access, Medical Affairs, and Health Economics and Outcomes Research (HEOR) teams in efficiently addressing key business questions related to patient enrollment and payer mapping.
Moreover, the increasing partnership and collaboration among the key market players are expected to drive market growth. For instance, in March 2024, Verantos announced a partnership with Curimeta to enhance the utilization of de-identified health data in clinical research. This collaboration focuses on improving real-world evidence generation while ensuring patient privacy through robust data de-identification processes. By leveraging Curimeta’s data science capabilities and Verantos’ expertise in real-world data, the partnership aims to provide valuable insights that can drive healthcare innovations and improve patient outcomes. The emphasis on de-identified data is crucial for facilitating secure data sharing and compliance with regulatory standards.
De-identified Health Data Market Report Highlights
- Based on the type of data, the clinical data segment dominated the market with almost 17% of the share in 2023. The segment’s dominance is attributed to its crucial role in research, treatment development, and patient care optimization
- Based on application, the clinical research and trials segment held the largest revenue share of 14.5% in 2023. This is attributed to its key role in advancing treatment methods, medical device innovation, and patient safety
- Based on the end use, the healthcare providers segment held the largest revenue share in 2023. The healthcare providers segment leads the market owing to its crucial role in clinical decision-making, treatment optimization, and patient outcome improvement
- North America dominated the market with a revenue share of 31.8% in 2023. The region has an advanced healthcare infrastructure and significant technological investment, particularly in data analytics and AI
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
The leading players in the De-identified Health Data market include:
- IQVIA
- Oracle (Cerner Corporation)
- Merative (Truven Health Analytics)
- Optum, Inc. (UnitedHealth Group)
- ICON plc
- Veradigm LLC (Formerly known as Allscripts)
- IBM
- Flatiron Health (F. Hoffmann-La Roche Ltd)
- Premier, Inc.
- Shaip
- Komodo Health, Inc.
- Evidation Health, Inc.
- Medidata
- Clarify Health Solutions
- Satori Cyber Ltd.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $7.45 Billion |
| Forecasted Market Value (USD) by 2030 | $13.59 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. De-identified Health Data Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.3. De-identified Health Data Market Analysis Tools
Chapter 4. De-identified Health Data Market: Type of Data Estimates & Trend Analysis
4.1. Type of Data Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global De-identified Health Data Market by Type of Data Outlook
4.4. Clinical Data
4.5. Genomic Data
4.6. Patient Demographics
4.7. Prescription Data
4.8. Claims Data
4.9. Behavioral Data
4.10. Wearable and Sensor Data
4.11. Survey and Patient-Reported Data
4.12. Imaging Data
4.13. Laboratory Data
4.14. Hospital and Provider Data
4.15. Social Determinants of Health (SDoH) Data
4.16. Pharmacogenomic Data
4.17. Biometric Data
4.18. Operational and Financial Data
4.19. Epidemiological Data
4.20. Healthcare Utilization Data
4.21. Others
Chapter 5. De-identified Health Data Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global De-identified Health Data Market by Mode of Delivery Outlook
5.4. Pharmaceutical Companies
5.5. Biotechnology Firms
5.6. Medical Device Manufacturers
5.7. Healthcare Providers
5.8. Insurance Companies/ Healthcare Payers
5.9. Research Institutions
5.10. Government Agencies
5.11. Others
Chapter 6. De-identified Health Data Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global De-identified Health Data Market by Application Outlook
6.4. Clinical Research and Trials
6.5. Public Health
6.6. Precision Medicine
6.7. Health Economics and Outcomes Research (HEOR)
6.8. Population Health Management
6.9. Drug Discovery and Development
6.10. Healthcare Quality Improvement
6.11. Insurance Underwriting and Risk Assessment
6.12. Market Access and Commercial Strategy
6.13. Business Intelligence and Operational Efficiency
6.14. Telemedicine and Remote Monitoring
6.15. Patient Engagement and Support Programs
6.16. Others
Chapter 7. De-identified Health Data Market: Regional Estimates & Trend Analysis, By Type of Data, By End use, By Application
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 – 2030:
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Innovators
8.4. Vendor Landscape
- IQVIA
- Oracle (Cerner Corporation)
- Merative (Truven Health Analytics)
- Optum, Inc. (UnitedHealth Group)
- ICON plc
- Veradigm LLC (Formerly known as Allscripts)
- IBM
- Flatiron Health (F. Hoffmann-La Roche Ltd)
- Premier, Inc.
- Shaip
- Komodo Health, Inc.
- Evidation Health, Inc.
- Medidata
- Clarify Health Solutions
- Satori Cyber Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/9jxots
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- De-identified Health Data Market
